-+ 0.00%
-+ 0.00%
-+ 0.00%

Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3

Benzinga·05/29/2024 21:20:31
Listen to the news

 Sarepta Therapeutics will replace Shockwave Medical in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.